Source: PR Newswire

Press Release: Klogene Therapeutics : A Boost of Klotho Protein Level Has Therapeutic Potential in Amyotrophic Lateral Sclerosis (ALS), Also Known as Lou Gehrig's Disease

BOSTON, June 27, 2019 /PRNewswire/ -- In a paper published today, scientists report that increasing the levels of the naturally occurring Klotho protein reduces the neurological deficits and prolongs life span in an experimental model of Amyotrophic Lateral Sclerosis (ALS), also known as...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Carmela Abraham's photo - Co-Founder of Klogene Therapeutics

Co-Founder

Carmela Abraham

CEO Approval Rating

75/100

Read more